Minimal Change Nephrotic Syndrome (MCNS)
Also known as: Nephrotic Syndrome, Minimal Change / Minimal change nephrotic syndrome / Nephrotic syndrome with lesion of minimal change glomerulonephritis / Minimal-change nephrotic syndrome / Minimal change disease (disorder) / Glomerulonephritis minimal lesion / Minimal change disease / Lipoid nephrosis / Nephrotic syndrome / Minimal change glomerulonephritis / Nephrosis, Lipoid / Nephrotic syndrome with unspecified morphologic changes / Syndrome nephrotic / Nephrotic syndrome (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00291 | Chlorambucil | A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas. |
DB00531 | Cyclophosphamide | A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00635 | Prednisone | 2 | Recruiting | 1 |
DB00073 | Rituximab | 2 | Recruiting | 1 |
DB00860 | Prednisolone | 4 | Completed | 1 |
DB00635 | Prednisone | 4 | Unknown Status | 1 |
DB00864 | Tacrolimus | 4 | Completed | 1 |